GT
BIIB icon

Glenview Trust’s Biogen BIIB Stock Holding History

Glenview Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,679
Closed -$342K – 406
2022
Q2 		$342K Sell
1,679
-391
-19% -$79.9K 0.01% 337
2022
Q1 		$436K Sell
2,070
-200
-9% -$43.5K 0.01% 320
2021
Q4 		$545K Sell
2,270
-3,121
-58% -$802K 0.02% 278
2021
Q3 		$1.53M Sell
5,391
-40
-0.7% -$13.1K 0.06% 167
2021
Q2 		$1.88M Sell
5,431
-877
-14% -$266K 0.07% 152
2021
Q1 		$1.76M Buy
6,308
+603
+11% +$163K 0.08% 148
2020
Q4 		$1.4M Buy
5,705
+2,228
+64% +$575K 0.06% 160
2020
Q3 		$986K Sell
3,477
-10
-0.3% -$2.79K 0.05% 177
2020
Q2 		$933K Buy
3,487
+53
+2% +$15.9K 0.05% 176
2020
Q1 		$1.09M Buy
3,434
+49
+1% +$14.9K 0.08% 161
2019
Q4 		$1M Sell
3,385
-814
-19% -$226K 0.06% 177
2019
Q3 		$977K Buy
4,199
+69
+2% +$16.1K 0.06% 179
2019
Q2 		$966K Sell
4,130
-4,037
-49% -$932K 0.06% 184
2019
Q1 		$1.93M Sell
8,167
-6,222
-43% -$1.96M 0.12% 141
2018
Q4 		$4.33M Sell
14,389
-17,423
-55% -$5.56M 0.32% 92
2018
Q3 		$11.2M Buy
31,812
+16
+0.1% +$5.51K 0.71% 42
2018
Q2 		$9.23M Buy
31,796
+446
+1% +$125K 0.69% 40
2018
Q1 		$8.58M Sell
31,350
-41
-0.1% -$12.7K 0.59% 52
2017
Q4 		$10M Buy
31,391
+199
+0.6% +$63.8K 0.69% 45
2017
Q3 		$9.77M Sell
31,192
-1,211
-4% -$359K 0.72% 46
2017
Q2 		$8.79M Buy
32,403
+85
+0.3% +$22.5K 0.68% 52
2017
Q1 		$8.84M Buy
32,318
+2,110
+7% +$597K 0.7% 47
2016
Q4 		$8.57M Buy
+30,208
New +$8.95M 0.71% 49
2015
Q4 		$5.92M Buy
+19,309
New +$5.55M 0.61% 57
2013
Q4 		$380K Buy
+1,359
New +$352K 0.04% 157

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Glenview Trust's BIIB Position: Q3 2022 in Review

Glenview Trust sold out of Biogen (BIIB) in Q3 2022, closing a stake of 1,679 shares — an estimated $342K sold.

Glenview Trust first reported a position in BIIB in Q4 2013 and held it in 25 quarters. The position peaked at $11.2M in Q3 2018. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

  • Glenview Trust reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
  • Glenview Trust sold 1,679 Biogen shares in Q3 2022, an estimated $342K.
  • Glenview Trust first reported a position in Biogen in Q4 2013 and held it in 25 quarters.
  • Glenview Trust's Biogen position peaked at $11.2M in Q3 2018.
  • 985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Glenview Trust's 13F filing for Q3 2022, filed 4 Nov 2022.